Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79,229Revenue (TTM) $M23,002Net Margin (%)15.8Altman Z-Score1.7
Enterprise Value $M89,564EPS (TTM) $1.4Operating Margin %22.0Piotroski F-Score6
P/E(ttm)23.1Beneish M-Score-2.7Pre-tax Margin (%)16.1Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %-2.5Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %-12.5Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow43.3y-y EBITDA Growth Rate %23.6ROA % (ttm)5.9Higher Current Ratio y-yN
Dividend Yield %4.5PEG--ROE % (ttm)25.0Less Shares Outstanding y-yN
Payout Ratio %101Shares Outstanding M2,530ROIC % (ttm)18.1Gross Margin Increase y-yY

Gurus Latest Trades with AZN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

AZN is held by these investors:

AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1784.18view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Causeway International Value Buys AstraZeneca, Gildan Mar 09 2017 
    Dodge & Cox Comments on AstraZeneca Feb 06 2017 
    Dodge & Cox's Stock Fund 4th Quarter Commentary Jan 16 2017 
    Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly Dec 10 2016 
    8 Uncommon Stocks NWQ Managers Is Buying Dec 06 2016 
    How Could a Potential Nexium Lawsuit Affect AstraZeneca? Nov 03 2016 
    Novo Nordisk Is Being Ignored Oct 06 2016 
    Novartis Is Surviving Oct 03 2016 
    10 Stocks Dodge & Cox Keep Buying Sep 22 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 

    More From Other Websites
    AstraZeneca Stock Rising in '17: What's Working in its Favor? Mar 23 2017
    Durvalumab and Tagrisso May Boost AstraZeneca’s Revenues in 2017 Mar 22 2017
    How AstraZeneca Controlled Operating Expenses in 2016 Mar 22 2017
    Novartis’ Heart Drug Fails Late Stage Trials (NVS, AZN) Mar 22 2017
    What Will Drive AstraZeneca’s Oncology Revenues in 2017? Mar 22 2017
    Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017 Mar 21 2017
    Why AstraZeneca’s Brilinta Could Become a Blockbuster Drug in 2017 Mar 21 2017
    What to Expect from AstraZeneca’s Farxiga in 2017 Mar 21 2017
    FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of... Mar 21 2017
    Pulmatrix Inhaled Drug Delivery Tech Gets EU Patent Mar 21 2017
    AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals Mar 20 2017
    Novel Diabetes Drugs Improve Heart Protection Mar 20 2017
    AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Mar 20 2017
    BUZZ-Circassia: Stifel raises to buy Mar 20 2017
    Newer type 2 diabetes drugs show heart protective quality in study Mar 19 2017
    AstraZeneca’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Hospitalizations for... Mar 19 2017
    Woodford-Backed Biopharma Stock Circassia Surges on Astra Pact Mar 17 2017
    $230M deal: AstraZeneca forms COPD drugs collaboration Mar 17 2017
    AstraZeneca Inks $230 Million COPD Drugs Deal Mar 17 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)